3-Methylhistidine.
Research-backed amino acid with potential health benefits. When you take it? Nothing. What it does in your body? It's a waste product released when muscle breaks down. High levels in urine mean you're losing muscle.
Reviewed March 2026
- Category
- Amino acid
What 3-Methylhistidine is, and what it does.
- Does it work
- No. It's a diagnostic tool, not a dietary supplement.
- How much to take
- Zero. Don't take it. There is no beneficial dose. It does not help you.
- Time to feel it
- There's no onset to time. It's read as a urine marker of muscle protein turnover, and the number moves with your diet and training rather than with a serving.
- The first dose
- Nothing. It will not make you stronger, faster, or improve your workout. It's just a modified amino acid your body will process and excrete.
- With regular use
- Zero long-term benefits. High levels of this *in your body* long-term are a bad sign, indicating chronic muscle breakdown from illness or malnutrition.
- How well tolerated
- It's likely safe, but entirely useless. The only danger is to your wallet.
- How it feels
- It feels like nothing. It's not a stimulant, not a relaxant, not an adaptogen. It's a metabolic footnote.
- The overlooked benefit
- Meat throws the reading off, because muscle foods carry it ready-made. That's why labs ask for about three meat-free days before they'll collect urine for it.
100 to 250mg a day is where 3-Methylhistidine works.
Source: Muscle catabolism biomarker research
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
3-Methylhistidine is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Index of myofibrillar protein breakdown in urineNarrative review
- Marker of muscle protein turnover across training and dietary changeRandomised trial
- Dietary muscle foods raising urinary outputNarrative review
- Contribution of smooth muscle and gut tissue to whole-body outputNarrative review
Questions people ask about 3-Methylhistidine.
- Will this help me build muscle?
- No. The opposite. It's a marker of muscle *breakdown*. High levels are a bad sign.
- Is this the same as L-Histidine?
- No. It's a byproduct made from histidine that's already in your muscles. Taking it doesn't help you make more muscle.
- Why is this sold as a supplement?
- Mostly for academic researchers, not for consumers. If it's in a consumer product, it's either filler or the formulator is confused.
- Should I get my 3-MH levels tested?
- Only if your doctor orders it to track specific medical conditions like muscular dystrophy or severe malnutrition. It's not a test for athletes.
- Is it found in food?
- Yes. Any meat contains it, especially chicken and turkey. Your body just digests it without any special benefit.
- Is there any reason at all to take this?
- For the average, healthy person, no. None. This is one to skip.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
3-methylhistidine is formed by post-translational methylation of specific histidine residues already built into actin and myosin, so histidine is its structural parent. The methylation happens on the assembled protein, not on free amino acid, and the modified residue cannot be recharged onto tRNA. That one-way step is why the compound leaves the body rather than being reused.
Leucine signals through mTORC1 to raise muscle protein synthesis and is described as reducing myofibrillar protein breakdown. Since urinary 3-methylhistidine is released when myofibrillar protein is degraded, leucine intake is one of the variables that moves the reading. What changes is a turnover marker, not a demonstrated change in muscle mass.
HMB is a leucine metabolite studied specifically for its reported effect on proteolytic signalling. Trials in this area routinely use 3-methylhistidine excretion as the readout for myofibrillar breakdown. The relationship is that HMB is the intervention and 3-methylhistidine is the marker, never the other way around.
Branched-chain amino acids are catabolised in skeletal muscle and are supplied together in most protein sources and supplements. Their availability influences the balance between synthesis and breakdown that 3-methylhistidine reports on. Reading a single branched-chain amino acid as the cause of a marker shift is not supported.
Whey delivers a rapid rise in plasma amino acids including leucine, which shifts net protein balance in the hours after intake. Studies tracking myofibrillar breakdown after protein feeding use urinary or plasma 3-methylhistidine as the measure. Whey itself contains no meaningful 3-methylhistidine, unlike a meat meal.
Casein clots in the stomach and releases amino acids slowly, a pattern often described as more suppressive of breakdown than of synthesis. That is the exact axis 3-methylhistidine reports on. As a dairy protein it does not itself add to the 3-methylhistidine pool the way skeletal muscle protein does.
Creatine is measured alongside 3-methylhistidine in muscle metabolism work because both relate to skeletal muscle mass, and creatinine is used to normalise urinary excretion. Supplemental creatine raises the creatinine pool, which can distort a 3-methylhistidine to creatinine ratio. Anyone reading that ratio needs to know whether creatine was taken.
Glutamine is the most abundant free amino acid in muscle and its efflux rises during catabolic states, alongside the myofibrillar breakdown that releases 3-methylhistidine. The two move together as markers of the same underlying state, which is an association between markers rather than one acting on the other. The direction of the relationship depends on the model and the setting, so it should not be read as a causal pairing.
Carnosine is beta-alanyl-L-histidine, and its methylated relatives anserine and balenine carry methylated histidine in a dipeptide. Meat, and particularly poultry and whale or marine muscle, supplies these dipeptides, which is one dietary route by which methylated histidine enters the body. That is why a urinary 3-methylhistidine reading needs a meat-free diet period to be interpretable.
Beta-alanine is the rate-limiting substrate for carnosine synthesis in muscle, the same histidine dipeptide family that includes the methylated forms. Raising muscle carnosine changes the histidine dipeptide pool. This is chemistry adjacent to 3-methylhistidine rather than a direct interaction with it.
A trial assessing urolithin A included protein metabolism among its measures, which is the setting where 3-methylhistidine is used as a breakdown marker. The pairing here is methodological: the compound is the intervention and 3-methylhistidine is one readout. Nothing about this establishes that either changes the other.
A randomised controlled trial of inulin supplementation profiled blood and faecal metabolites, the class of measurement in which 3-methylhistidine appears. Fermentable fibre shifts the metabolome broadly rather than acting on muscle protein turnover specifically. Read any 3-methylhistidine movement in that setting as one metabolite among many.
A supplementation study in older adults with reduced muscle mass and strength used muscle turnover measures of the kind 3-methylhistidine belongs to. The relevance is that the marker is read in that population, not that the extract acts on the marker. The design is open-label and the finding is preliminary.
Nothing specific on file for 3-Methylhistidine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What 3-Methylhistidine actually does.
3-methylhistidine is not incorporated from the free amino acid pool. It is created after translation, when a specific histidine residue in actin and in myosin heavy chain is methylated on the already-assembled protein.
Once released by proteolysis of myofibrillar protein, 3-methylhistidine cannot be charged onto tRNA or reused for protein synthesis, and in humans it is not appreciably metabolised, so it is excreted in urine largely unchanged.
Because release is one-way and excretion is near-quantitative, urinary 3-methylhistidine is used as an index of myofibrillar protein breakdown. It is a marker of a rate, never a measure of muscle mass or of a clinical outcome.
Skeletal muscle holds most but not all of the body pool. Smooth muscle and gut tissue also contain actin bearing the methylated residue and turn over faster than skeletal muscle, which is one reason whole-body excretion overstates the skeletal muscle contribution.
Where 3-Methylhistidine comes from.
This is made in a lab, not pulled from a plant or an animal. Chemists start with ordinary histidine and add a single methyl group to one exact spot on the ring, then clean the product carefully because adding it to the wrong spot gives a different molecule entirely. In the body it is not manufactured this way at all: it appears when muscle protein is broken down, which is why labs measure it in urine.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Commercial L-histidine, itself typically produced by bacterial fermentation, is the usual starting material for the methylated analogue.
The imidazole ring is methylated at the tau nitrogen using a methylating agent under conditions chosen to control regiochemistry, since methylation at the other ring nitrogen gives 1-methylhistidine instead. Amine and carboxyl groups are protected during the step and deprotected afterwards.
The crude product is separated from the unmethylated starting material and the regioisomer by ion-exchange chromatography, then crystallised, often as the hydrochloride.
Identity is confirmed by NMR and mass spectrometry, chiral purity by chromatography, and the 1-methyl regioisomer is quantified separately because the two are functionally different molecules.
Supplied as a dried crystalline powder or as a certified reference solution for analytical use.
Getting 3-Methylhistidine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Dileucine-supplemented essential amino acids were reported to support whole-body anabolism after resistance exercise, with muscle protein turnover measures including 3-methylhistidine among the readouts; these are turnover markers, not changes in muscle size.Randomised trial. Aguilera et al., 2025 (Journal of the International Society of Sports Nutrition). PMID 41321015 â
- Urolithin A supplementation was assessed against muscle endurance, strength, inflammation, oxidative stress and protein metabolism measures, the last of which is where 3-methylhistidine functions as a breakdown marker.Randomised trial. Zhao et al., 2024 (Journal of the International Society of Sports Nutrition). PMID 39487653 â
- A randomised controlled trial of inulin supplementation profiled faecal and blood metabolomes; metabolite shifts of this kind are markers of altered metabolism rather than clinical outcomes.Randomised trial. Amadieu et al., 2025 (Clinical Nutrition ESPEN). PMID 39864520 â
- A supplementation study in older adults with loss of muscle mass and strength reported muscle mass and strength measures; the design is open-label supplementation, so the finding is preliminary and not controlled.Open-label trial. Belcaro et al., 2026 (Minerva Medica). PMID 41800904 â
- Muscle growth and protein turnover were measured during a backgrounding period in cattle receiving anabolic implants and supplementation; 3-methylhistidine serves as a myofibrillar breakdown index in this kind of livestock turnover work.Animal study. Jacobs et al., 2025 (Animals). PMID 40002995 â
These are the studies our verdict leans on, chosen from the 5 we read for 3-Methylhistidine. The full linked list is below.
The studies, linked.
2 sources behind our 3-Methylhistidine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialRandomised Cross-over Single-site Study on the Bioavailability of Citrulline After an Oral Bolus of Citrulline, Glutamine, Arginine, 3-Methylhistidine or Placebo in Healthy SubjectsClinicalTrials.gov âNA ¡ 20 participants ¡ Completed
- Clinical trialNon-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase 2ClinicalTrials.gov â8 participants ¡ Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.